IP Library Granted Patent US 10,449,217
Granted Patent B2
US 10,449,217 · App. 15/465,092 · Granted Oct 22, 2019

Gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor

Inventors: Mark Gordon Mortenson (North East, MD); D. Kyle Pierce (Elkton, MD); David A. Bryce (Elkton, MD); Reed N. Wilcox (Littleton, CO); Anthony Lockett (Leeds, GB); Mikhail Merzliakov (Parkville, MD)
Assignee: Clene Nanomedicine, Inc.
A61K33/24A61K9/0095A61K9/08A61K9/10A61K9/14A61K47/02B22F1/0022B22F9/00B82Y30/00C30B7/12C30B29/02C30B29/60B22F2001/0037Y02A50/401Y02A50/411
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,449,217
App. No.
15/465,092
Granted
Oct 22, 2019
Kind
B2
Abstract

The present invention relates to novel gold nanocrystals and nanocrystal shape distributions that have surfaces that are substantially free from organic impurities or films. Specifically, the surfaces are “clean” relative to the surfaces of gold nanoparticles made using chemical reduction processes that require organic reductants and/or surfactants to grow gold nanoparticles from gold ions in solution. The invention includes novel electrochemical manufacturing apparatuses and techniques for making the gold-based nanocrystals. The invention further includes pharmaceutical compositions thereof and the use of the gold nanocrystals or suspensions or colloids thereof for the treatment or prevention of diseases or conditions for which gold therapy is already known and more generally for conditions resulting from pathological cellular activation, such as inflammatory (including chronic inflammatory) conditions, autoimmune conditions, hypersensitivity reactions and/or cancerous diseases or conditions. In one embodiment, the condition is mediated by MIF (macrophage migration inhibiting factor).

Claims (69)

1. A suspension comprising:

a.) water;

b.) at least one processing enhancer comprising at least one material selected from the group consisting of sodium bicarbonate, sodium carbonate, potassium bicarbonate, potassium carbonate, trisodium phosphate, disodium phosphate, monosodium phosphate, and potassium phosphates;

c.) gold nanocrystals suspended in said water forming a suspension, wherein said gold nanocrystals:

i.) having surfaces that do not have organic chemical constituents adhered or attached to said surfaces;

ii.) having a mode particle size of less than about 50 nm;

iii.) are present in said suspension at a concentration of at least 2 ppm by weight per volume; and

d.) said suspension having a pH of between about 5 to about 9.5, said gold nanocrystals having a zeta potential of about −20 mV or lower at a temperature of about 25° C., said zeta potential being determined by measuring the electrophoretic mobility of the gold nanocrystals in the suspension, and the suspension does not contain chloride ions.

2. The suspension of claim 1 , wherein said gold nanocrystals have a zeta potential of about −30 mV or lower.

3. The suspension of claim 1 , wherein said gold nanocrystals have a zeta potential of about −40 mV or lower.

4. The suspension of claim 1 , wherein said gold nanocrystals have a zeta potential of about −50 mV or lower.

5. The suspension of claim 1 , wherein said gold nanocrystals have shapes comprising faces with spatially extended low index crystal planes, said shapes appearing as triangles and pentagons.

6. The suspension of claim 5 , wherein said shaped gold nanocrystals further comprise shapes which appear as hexagons and diamond shapes.

7. The suspension of claim 1 , wherein said gold nanocrystals are present at a concentration of about 2-200 ppm by weight per volume.

8. A composition comprising:

a.) a suspension medium comprising water and at least one processing enhancer comprising sodium bicarbonate dissolved therein, said suspension medium having a pH of between about 5 to about 9.5; and

b.) shaped gold nanocrystals in said suspension medium forming a suspension, said shaped gold nanocrystals having a zeta potential of about −20 mV or lower at a temperature of about 25° C., said zeta potential being determined by measuring the electrophoretic mobility of the shaped gold nanocrystals in the suspension; wherein said shaped gold nanocrystals:

i.) having surfaces that do not have organic chemical constituents adhered or attached to said surfaces;

ii.) having a mode particle size of less than about 50 nm;

iii.) are present in said suspension at a concentration of at least about 2 ppm by weight per volume; and

iv.) having shapes comprising low Miller index crystal planes.

9. The suspension of claim 8 , wherein said shaped gold nanocrystals having a zeta potential of about −40 mV or lower.

10. The suspension of claim 8 , wherein said mode particle size is within a range of about 8-18 nm and said pH is between 8 to about 9.5.

11. The suspension of claim 10 , wherein said shaped gold nanocrystals having said low Miller index crystal planes comprising triangle and pentagon shapes.

12. The suspension of claim 11 , wherein said shaped gold nanocrystals having said low Miller index crystal planes further comprise hexagon and diamond shapes.

13. A suspension comprising:

a.) a suspension medium comprising water and sodium bicarbonate dissolved therein, said suspension medium having a pH of between about 5 to about 9.5;

b.) shaped gold nanocrystals in said suspension medium forming a suspension, said shaped gold nanocrystals having a zeta potential of about −30 mV or lower at a temperature of about 25° C., said zeta potential being determined by measuring the electrophoretic mobility of the shaped gold nanocrystals in the pharmaceutical suspension; and wherein said shaped gold nanocrystals:

i.) having surfaces that do not have organic chemical constituents adhered or attached to said surfaces;

ii.) having a mode particle size of less than about 30 nm;

iii.) are present in said suspension at a concentration of at least about 2 ppm by weight per volume; and

iv.) comprise triangle and pentagon shapes.

14. The suspension of claim 13 , wherein said shaped gold nanocrystals have a zeta potential of about −40 mV or lower.

15. The suspension of claim 13 , wherein said shaped gold nanocrystals having a mode particle size within a range of about 8-18 nm.

16. The suspension of claim 13 , wherein said shaped gold nanocrystals having a mode particle size of less than about 21 nm and having a zeta potential of about −40 mV or lower.

17. The suspension of claim 13 , wherein said shaped gold nanocrystals further comprising hexagon and diamond shapes.

18. The suspension of claim 13 , wherein said suspension does not contain chloride ions.

19. The suspension of claim 13 , wherein said shaped gold nanocrystals are present in said suspension at a concentration of about 2-200 ppm.

20. The suspension of claim 13 , wherein said shaped gold nanocrystals having a mode particle size within a range of about 8-18 nm and the suspension has a pH of between about 8 to about 9.5.

21. The suspension of claim 13 , wherein said pH is between about 8 and about 9.5, said mode particle size is within a range of about 8-18 nm, and said zeta potential is about −40 mV or lower.

22. The suspension of claim 1 , wherein said pH is between about 8 and about 9.5, said mode particle size is within a range of about 8-18 nm, and said zeta potential is about −40 mV or lower.

23. The suspension of claim 6 , wherein said pH is between about 8 and about 9.5, said mode particle size is within a range of about 8-18 nm, and said zeta potential is about −40 mV or lower.

24. The suspension of claim 7 , wherein said pH is between about 8 and about 9.5, said mode particle size is within a range of about 8-18 nm, and said zeta potential is about −40 mV or lower.

25. The suspension of claim 4 , wherein said gold nanocrystals comprise shapes comprising low Miller index crystal planes, said shapes appearing as triangles and pentagons.

26. The suspension of claim 7 , wherein said pH is between about 8 and about 9.5, said mode particle size is within a range of about 8-18 nm, and said zeta potential is about −40 mV or lower.

27. The suspension of claim 3 , wherein said gold nanocrystals are shaped and comprising at least one low Miller index {111} crystal plane.

28. The suspension of claim 1 , wherein said gold nanocrystals are shaped and include least one low Miller index crystal plane selected from the group of crystal planes consisting of {111}, {110} and {100}.

29. The suspension of claim 1 , wherein said gold nanocrystals are shaped and comprising at least one low Miller index {111} crystal plane.

30. The suspension of claim 1 , wherein said gold nanocrystals have a mode particle size of less than about 30 nm.

31. The suspension of claim 1 , wherein said gold nanocrystals have a mode particle size within a range of about 8-18 nm.

32. A composition comprising:

a.) water and NaHCO 3 dissolved therein,

b.) gold nanocrystals suspended in said water forming a suspension, wherein said gold nanocrystals:

i.) having surfaces that do not have organic chemical constituents adhered or attached to said surfaces;

ii.) having a mode particle size of less than about 50 nm;

iii.) are present in said suspension at a concentration of at least 2 ppm (w/v);

iv.) are shaped and comprising at least one low Miller index crystal plane selected from the group of crystal planes consisting of {111}, {110} and {100}; and

c.) said suspension having a pH of between about 8 to about 9.5, said gold nanocrystals have a zeta potential of about −30 mV or lower at a temperature of about 25° C., said zeta potential being determined by measuring the electrophoretic mobility of the gold nanocrystals in the suspension, and the suspension does not contain chloride ions.

33. The suspension of claim 32 , wherein said gold nanocrystals have shapes comprising faces with spatially extended low index crystal planes, said shapes appearing as triangles and pentagons when dried from suspension on a surface.

34. The suspension of claim 33 , wherein said shaped gold nanocrystals further comprise hexagon and diamond shapes.

35. The suspension of claim 32 , wherein said at least one low Miller index crystal plane comprises a crystal plane {111}.

36. [Newly Added] A suspension comprising:

a.) water;

b.) at least one processing enhancer comprising potassium bicarbonate;

c.) gold nanocrystals suspended in said water forming a suspension, wherein said gold nanocrystals:

i.) having surfaces that do not have organic chemical constituents adhered or attached to said surfaces;

ii.) having a mode particle size of less than about 50 nm;

iii.) are present in said suspension at a concentration of at least 2 ppm by weight per volume; and

d.) said suspension having a pH of between about 5 to about 9.5, said gold nanocrystals having a zeta potential of about −20 mV or lower at a temperature of about 25° C., said zeta potential being determined by measuring the electrophoretic mobility of the gold nanocrystals in the suspension, and the suspension does not contain chloride ions.

Assignments (2)
SECURITY INTEREST Recorded Dec 31, 2024
From: CLENE INC.; CLENE NANOMEDICINE, INC.
To: KENSINGTON CLENE 2024 LLC
Reel/Frame 069831/0501 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2017
From: GR INTELLECTUAL RESERVE, LLC
To: CLENE NANOMEDICINE, INC.
Reel/Frame 043889/0220 →
Continuity (9)
Division 13382781
Provisional Application 61294690 · Jan 13, 2010
Provisional Application 61263648 · Nov 23, 2009
Provisional Application 61249804 · Oct 8, 2009
Provisional Application 61235574 · Aug 20, 2009
Provisional Application 61228250 · Jul 24, 2009
Provisional Application 61226153 · Jul 16, 2009
Provisional Application 61223944 · Jul 8, 2009
Related Publication 20170348350A1 · Dec 7, 2017